The effect of pregabalin in the treatment of schizophrenia

Not Applicable

• Conditions: Schizophrenia.; schizophrenia

• Registration Number: IRCT2015092711885N7
• Lead Sponsor: Vice chancellor for research, Mazandaran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Other
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

1. Diagnosis of schizophrenia according to DSM-V criteria by psychiatrist
2. Age 18 to 65 years
3. Informed consent / guardian for inclusion
4. Treatment with antipsychotics
5. Refractory schizophrenia
Exclusion criteria:
1. Other psychiatric disorders axis I or II exist
2. Serious or chronic diseases like renal and liver dysfunction, severe diarrhea, cardiovascular disease, urinary tract infection, head injury
3. Pregnancy
4. Breastfeeding
5. Lack of appropriate contraception in women of reproductive age
6. Substance abuse over the past month
7. Intolerable side effects
8. History of allergy to Pregabalin
9. Change the doses of antipsychotic agents during last two weeks
10. Patient/ guardian’s apply to withdraw from the study

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified